XPEV XPeng Inc tops Q4 2025 EPS estimates by wide margin shares climb nearly 5 percent on upbeat investor reaction RVMD Revolution Medicines edges higher after reporting wider than expected Q4 2025 per share loss NCS NCSM Stock diluted Shares Investor Interest 20260427